Medical device electrical cable, general purpose Australien - engelska - Department of Health (Therapeutic Goods Administration)

medical device electrical cable, general purpose

smiths medical australasia pty ltd - 47487 - medical device electrical cable, general purpose - the device is to be used to provide an electrical connection between the patient and a pressure monitoring transducer. single or multiple channel variations of this device are available.

Medical adhesive remover, non-sterile Australien - engelska - Department of Health (Therapeutic Goods Administration)

medical adhesive remover, non-sterile

liberty medical pty ltd - 60494 - medical adhesive remover, non-sterile - adapt medical adhesive remover is used to safely and gently remove medical adhesives

Medical gas delivery line filter, endoscopy Australien - engelska - Department of Health (Therapeutic Goods Administration)

medical gas delivery line filter, endoscopy

teleflex medical australia pty ltd - 60837 - medical gas delivery line filter, endoscopy - the bacterial /viral filter is intended for humidification and bacterial/viral filtration during anaesthesia and intensive care. the bacterial /viral filter filters the inspired air and protects the patient circuit and the ventilator or anaesthesia machine from contamination. catheter mounts are used in anaesthesia and intensive care to receive flexibility between the patient and breathing system, also as connectors for breathing circuits, and for circuit-patient connection.

CO-DIOVAN 320/25 mg valsartan 320 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack Australien - engelska - Department of Health (Therapeutic Goods Administration)

co-diovan 320/25 mg valsartan 320 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 320 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; crospovidone; hypromellose; purified talc; iron oxide yellow; macrogol 4000; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 320/12.5 mg valsartan 320 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australien - engelska - Department of Health (Therapeutic Goods Administration)

co-diovan 320/12.5 mg valsartan 320 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 320 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; microcrystalline cellulose; magnesium stearate; hypromellose; purified talc; iron oxide red; macrogol 4000; iron oxide black; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

None None Medical Regulator Flow Filippinerna - engelska - FDA (Food And Drug Administration)

none none medical regulator flow

davao int'l mega gas corporation - medical grade oxygen - medical regulator flow - none

CO-DIOVAN 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack Australien - engelska - Department of Health (Therapeutic Goods Administration)

co-diovan 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 160 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; colloidal anhydrous silica; hypromellose; purified talc; iron oxide yellow; macrogol 4000; iron oxide red; iron oxide black; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 160/12.5 valsartan 160 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australien - engelska - Department of Health (Therapeutic Goods Administration)

co-diovan 160/12.5 valsartan 160 mg and hydrochlorothiazide 12.5 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide red; macrogol 8000; magnesium stearate; hypromellose; colloidal anhydrous silica - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australien - engelska - Department of Health (Therapeutic Goods Administration)

co-diovan 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 80 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; iron oxide yellow; colloidal anhydrous silica; crospovidone; purified talc; magnesium stearate; hypromellose; macrogol 8000; iron oxide red; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

Medical image management system Australien - engelska - Department of Health (Therapeutic Goods Administration)

medical image management system

pentax medical singapore pte ltd - 60723 - medical image management system - to electronically receive, transfer, collect, store, and display a broad range of medical imaging/video data